Irvine-based Pharmaron, a provider of R&D services to the pharmaceutical and biotech industry, said last week that it has raised $40M in a Series C funding round. The round came from DCM, Legend Capital, GL Capital Group, and others. The firm said the new funding will go to expand its discovery services offerings, preclinical GLP toxicology capabilities and GMP chemical synthesis services. Pharmaron's west coast headquarters is in Irvine, with east coast headquarters in Kentucky. More information »